Exclusion criteria of the NanoTherm ® Therapy

Important

The electronic survey provided below is to assist patients in obtaining initial information on the possibility of using NanoTherm ® Therapy (NTT) to treat a brain tumour in their case.

The results of the survey in question do not guarantee any particular medical assessment, nor a positive decision on being qualified to undergo this therapy.

Being qualifiable to undergo NTT may be assessed solely by a specialist physician, after submitting all the required medical data to a clinical centre named at the end of this survey.

The provider of this website disclaims any responsibility for the results of the survey in question, nor does he require and file any personal data or information on the state of health of a patient.

To initially assess whether NanoTherm ® Therapy could be conducted in the case of a particular patient, first and foremost, it should be verified whether anything excludes using it.

Since 2011, all the components of the System of NanoTherm ® Therapy have had the CE (‘European Certification’), and, ipso facto, this therapy has been officially approved of for the purpose of treating brain tumour in all the countries of the European Union.

NanoTherm ® Therapy consists in injecting a fluid having magnetic properties, which is then heated up with the use of a very rapidly changing magnetic field, into a tumour. The impact of the generated heat destroys neoplastic cells or sensitises them to further treatment methods such as radiotherapy or chemotherapy, which improves their effectiveness. However, it is extremely important that all metallic materials located within no more than, approximately, 40 cm from the brain tumour, must be removed
or replaced with non-metallic materials as they would otherwise also be heated up. 

The presence of metallic elements in / on patient’s body if these cannot be removed or replaced is one of the exclusion criteria of conducting NanoTherm ® Therapy. 

Answers to the questions hereinabove will allow you to obtain information on the possibility of conducting the therapy.

Has the patient been diagnosed with a brain tumor?

  • YES
  • NO

Is the patient of legal age?

  • YES
  • NO

Does the patient's state of health make it possible to transport them?

  • YES
  • NO

Is the patient pregnant (if female)?

  • YES
  • NO

Please, tick off any electronic device indicated below that the patient uses

  • Cardiac pacemaker

    A device generating electrical impulses artificially stimulating the cardiac muscle

  • Cardioverter/Defibrillator

    Cardioverter-defibrillator, commonly referred to as an ICD, is a device able to diagnose a life- threatening arrhythmia and restore regular heart rhythm

  • Neurostimulator

    Neurostimulator is a surgically-implanted stopper-size device. It sends gentle electrical signals to the epidural space near the spinal cord through at least 1 input cables (special-purpose wires). These electrical signals ‘mask’ backache and pain in the legs replacing it with pleasant tingling

  • Other electronic implants, e.g. of the ear
  • No

Please, tick off if there are following metallic materials in the region of the head and neck:

Metallic materials in the organism at the distance of approximately 40 cm from a brain tumour must be replaced with non-metallic (plastic) materials because all and any metallic materials would be heated up in the course of conducting NanoThermheerapy. These include:
  • Irremovable dental fillings
  • Irremovable crowns and bridges
  • Heart valves
  • Prostheses of the shoulder joint
  • Tattoos with metallic compounds
  • Plaques, screws and wires

    (usually made of metal and used to stabilise bone fractures)

  • Other irremovable or irreplaceable implants or metallic elements
  • None

Is the brain tumour multifocal / is there more than one tumour?

  • YES
  • NO

Has the patient undergone a therapy with the use of Avastin/Bevacizumab in the last 6 weeks?

  • YES
  • NO

Thank you for completing the survey!

Patient is qualifiable to undergo a medical consultation

Obtain the assistance of the Alivia Oncological Foundation
www.alivia.org.pl

Find out more on MediiMe
www.mediime.com

In order to make an appointment for a medical consultation, please send:

  • The information on the current neurological state of a patient,
  • A CD with the MRI examination of the head, conducted with the use of a contrast medium (no older than 1 month),
  • Contact data

to the following address:

Office of the Chair and Clinic of Neurosurgery and Infant Neurosurgery
Independent Public Teaching Hospital No 4 in Lublin
ul. Jaczewskiego 8,
20-954 LUBLIN

A decision on the initial qualification to undergo NanoTherm ® Therapy is made by specialist physicians on the basis of the above-mentioned documents; patients initially qualified will be invited for the final qualification to the Clinic of Neurosurgery of the Medical University in Lublin to be consulted after making prior phone arrangements.

Enter your e-mail address to as to receive the above-mentioned information:

If you need assistance to undergo rapidly:
MR examination

Kolejkoskop.pl – find out where the queue to an examination financed by the NHF is the shortest

Cenomed.pl – find an examination. Compare prices. Arrange a visit.

Obtain the assistance of the Alivia Oncological Foundation
www.alivia.org.pl

Find out more on MediiMe
www.mediime.com

Thank you for completing the survey!

The answers indicate that a patient is not qualifiable to undergo NanoTherm ® Therapy.
Consult a specialist physician about other options of treatment.

If you wish to receive information about new examinations, enter your e-mail address below:

Obtain the assistance of the Alivia Oncological Foundation
www.alivia.org.pl

Find out more on MediiMe
www.mediime.com